GenScript Biotech Corporation expanded its collaboration with Roche

This collaboration underscores the mutual commitment to pushing the boundaries of scientific discovery

GenScript Biotech Corporation ("GenScript"), a prominent figure in the realm of life science research tools and services on a global scale, announces an extension of its partnership with Roche. Since 2011, GenScript and Roche have been engaged in a collaborative endeavor under a Laboratory Service Agreement, encompassing a spectrum of services and products provided by GenScript worldwide. Now, they have elevated their cooperative efforts with the aim of propelling innovation across their respective portfolios. Ray Chen, President of the Life Science Group at GenScript, expressed enthusiasm about this development, saying that the extension of its collaboration with Roche marks a significant milestone. It reflects our shared dedication to catalyzing groundbreaking advancements in medical diagnostics.

Through the fusion of our technological expertise, the company is well-positioned to deliver unmatched innovation that will ultimately enhance the well-being of patients and satisfy the needs of customers worldwide. This expanded collaboration between GenScript and Roche underscores their mutual commitment to pushing the boundaries of scientific discovery and improving healthcare outcomes. By leveraging their complementary strengths and resources, the organization aspires to introduce transformative solutions that address critical challenges in the field of life sciences. With a focus on innovation and customer-centricity, both entities are poised to make substantial contributions to the advancement of medical diagnostics and beyond.